Table 3 Percentage of DPMSCÂ expressing surface ligands of natural killer (NK) activating receptors (DNAM-1 and NKG2D) and the ligands of NK inhibiting receptor (HLA-E)
DNAM-1 ligands | NKG2D ligands | CD94/NKG2 ligand | HLA-ABC | |||||
|---|---|---|---|---|---|---|---|---|
PVR (CD155) | Nectin-2 (CD112) | ULBP-1 | ULBP-2 | ULBP-3 | MICA | MICB | HLA-E | |
1.00% ± 0.18% | 63.26% ± 8.18% | 7.95% ± 1.33% | 22.85% ± 5.37% | 5.63% ± .0.68% | 31.91% ± 5.67% | 22.40% ± 4.48% | 30.93% ± 8.36% | 95.60% ± 3.40% |